2022-06-17
Coronavirus-(COVID-19)-Update-FDA-Authorizes-Moderna-and-Pfizer-BioNTech-COVID-19-Vaccines-for-Children-Down-to-6-Months-of-Age-FDA
"Safety
The safety data to support the Moderna COVID-19 Vaccine EUA in individuals 6 months through 17 years of age are as follows:
Children 6 months through 5 years of age: Safety was evaluated in approximately 1,700 children 6 through 23 months of age who received the vaccine and 600 who received the placebo. Of these, approximately 1,100 vaccine recipients were followed for safety for at least two months following the second dose. For participants 2 through 5 years of age, approximately 3,000 received the vaccine and approximately 1,000 received a placebo; approximately 2,200 vaccine recipients were followed for safety for at least two months following the second dose."
https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-moderna-and-pfizer-biontech-covid-19-vaccines-children
Coronavirus-(COVID-19)-Update-FDA-Authorizes-Moderna-and-Pfizer-BioNTech-COVID-19-Vaccines-for-Children-Down-to-6-Months-of-Age-FDA
"Safety
The safety data to support the Moderna COVID-19 Vaccine EUA in individuals 6 months through 17 years of age are as follows:
Children 6 months through 5 years of age: Safety was evaluated in approximately 1,700 children 6 through 23 months of age who received the vaccine and 600 who received the placebo. Of these, approximately 1,100 vaccine recipients were followed for safety for at least two months following the second dose. For participants 2 through 5 years of age, approximately 3,000 received the vaccine and approximately 1,000 received a placebo; approximately 2,200 vaccine recipients were followed for safety for at least two months following the second dose."
https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-moderna-and-pfizer-biontech-covid-19-vaccines-children